Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-22-018613

Chief Executive Officer gave up 9,640 shares (to pay taxes)

  • Chief Executive Officer acquired 20,834 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2022-03-10 Option exercise +11,834 290,919 D
Kulkarni Samarth Chief Executive Officer 2022-03-11 Shares withheld for taxes −5,487 $62.56 $343,267 285,432 D
Kulkarni Samarth Chief Executive Officer 2022-03-11 Option exercise +9,000 294,432 D
Kulkarni Samarth Chief Executive Officer 2022-03-14 Shares withheld for taxes −4,153 $61.08 $253,665 290,279 D
Derivatives
Kulkarni Samarth Chief Executive Officer 2022-03-10 Option exercise · Restricted Stock Units −11,834 11,833 D
Kulkarni Samarth Chief Executive Officer 2022-03-11 Option exercise · Restricted Stock Units −9,000 27,000 D
Loading xslF345X03/doc4.xml…